Bausch Health Companies Inc. buy Vassago1
Start price
08.11.16
/
50%
€14.01
Target price
08.05.17
€15.33
Performance (%)
-37.00%
End price
08.05.17
€8.83
Summary
This prediction ended on 08.05.17 with a price of €8.83. The BUY prediction by Vassago1 for Bausch Health Companies Inc. performed very badly with a performance of -37.00%. Vassago1 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bausch Health Companies Inc. | -22.303% | -22.303% | -37.143% | -77.708% |
| iShares Core DAX® | 0.039% | 0.567% | 12.281% | 14.748% |
| iShares Nasdaq 100 | -4.018% | -5.554% | 23.851% | 36.769% |
| iShares Nikkei 225® | -2.389% | -1.434% | 8.335% | 5.073% |
| iShares S&P 500 | -2.115% | -2.351% | 22.061% | 37.971% |
Comments by Vassago1 for this prediction
In the thread Bausch Health Companies Inc. diskutieren
VRX
The Canadian firm now expects adjusted earnings of $5.30 to $5.50 a share on $9.55 billion to $9.65 billion in sales for the year. That is down sharply from its previous guidance for earnings of $6.60 to $7 a share and revenue between $9.9 billion and $10.1 billion.
(Laufzeit überschritten)